HealthCor Partners Management, L.P. is a prominent U.S. healthcare-focused growth-equity / late-stage private equity firm founded in 2008 and based in New York City, New York. The firm invests in healthcare, life-sciences, medical-technology and devices, therapeutics, healthcare-services, and adjacent healthcare-growth themes at later-stage and growth-equity rounds. HealthCor Partners was founded by Co-Founders Joe Healey and Arthur Cohen alongside partners (note: HealthCor Partners Management is distinct from the earlier HealthCor Management, L.P. hedge-fund founded by the same principals; the Partners entity focused on private investments while HealthCor Management operated the long/short healthcare hedge fund). HealthCor Partners has raised multiple institutional funds including HealthCor Partners Fund I and II, with aggregate AUM approaching or exceeding USD 1 billion+ across vintages. Notable portfolio companies have included Intersect ENT (acquired by Medtronic for USD 1.1 billion in 2021), Paratek Pharmaceuticals (NASDAQ: PRTK, IPO 2014), HeartFlow, Tenaya Therapeutics, Exagen Inc. (NASDAQ: XGN), and various other healthcare growth-stage companies producing multiple IPO and acquisition exits.